EUDA Health Holdings Ltd
EUDAdata completeness 88%6 fiscal years on fileData notes: no data for concept 'totalDebt'; no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'dividendsPaid'; no data for concept 'interestExpense'
| Figure | FY 2022 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | — | $3.76M1 | $3.71M2 | $4.01M2 | $6.82M2 |
| Net income | −$1.76M3 | −$24.9M4 | −$10M5 | −$15.4M5 | −$2.77M5 |
| Operating cash flow | −$1.01M6 | −$1.53M7 | −$2.92M8 | −$2.03M8 | −$2.43M8 |
| Capital expenditure | — | $18,1379 | — | $96,76210 | $77,26410 |
| Free cash flow (derived) | — | −$1.54M7 | — | −$2.13M8 | −$2.5M8 |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $193,54611 | $57,54112 | $189,00512 | $237,60513 | $345,14413 |
| Diluted shares | 2.4M | 12.0M | 1.1M | 1.6M | 1.9M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on −$22.78 of net worth that earned you −$14.85 and generated −$13.41 of cash last year.
Not enough data in the filings for a return-on-capital reading.
seeing a moat in the numbers →Share count is down 24% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 20-F/A · period ending 2022-12-31 · accession 0001493152-25-014808 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 20-F · period ending 2023-12-31 · accession 0001493152-26-019361 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-07-31 · accession 0001493152-22-024263 (NetIncomeLoss)
- 20-F/A · period ending 2022-12-31 · accession 0001493152-25-014808 (NetIncomeLoss)
- 20-F · period ending 2023-12-31 · accession 0001493152-26-019361 (NetIncomeLoss)
- 10-K · period ending 2022-07-31 · accession 0001493152-22-024263 (NetCashProvidedByUsedInOperatingActivities)
- 20-F/A · period ending 2022-12-31 · accession 0001493152-25-014808 (NetCashProvidedByUsedInOperatingActivities)
- 20-F · period ending 2023-12-31 · accession 0001493152-26-019361 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001493152-23-022805 (PaymentsToAcquirePropertyPlantAndEquipment)
- 20-F · period ending 2024-12-31 · accession 0001493152-26-019361 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-07-31 · accession 0001493152-22-024263 (CashAndCashEquivalentsAtCarryingValue)
- 20-F · period ending 2022-12-31 · accession 0001493152-24-018280 (CashAndCashEquivalentsAtCarryingValue)
- 20-F · period ending 2024-12-31 · accession 0001493152-26-019361 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)